TAMPA GENERAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $14.4M
- Transactions
- 2,224
- Companies
- 40
- Average per transaction
- $6,467
Who reported the payments
| Gilead | $2,275,965 |
| Diasorin Molecular LLC | $897,037 |
| Roche Diagnostics Operations, Inc. | $823,603 |
| Luminex Corporation | $794,515 |
| Organox Ltd | $597,094 |
| AbbVie | $566,371 |
| Merck | $506,024 |
| Biofire Diagnostics, LLC | $490,593 |
| Paragonix Technologies, Inc. | $466,298 |
| United Therapeutics Corporation | $447,081 |
| Vertex | $396,533 |
| Daiichi Sankyo Inc. | $328,636 |
| T2 Biosystems, Inc. | $321,760 |
| Chromacode, Inc | $314,884 |
| Intercept Pharmaceuticals, Inc. | $300,566 |
| Modernatx, Inc. | $297,944 |
| Qiagen, LLC | $288,205 |
| AstraZeneca | $248,143 |
| Pfizer | $226,965 |
| Abbott | $220,747 |
| Biomerieux Inc | $195,769 |
| Beone Medicines USA, Inc. | $168,215 |
| CSL Behring | $147,616 |
| Acell, Inc. | $144,404 |
| Syndax Pharmaceuticals, Inc. | $121,829 |
| Stryker | $114,164 |
| Zimmer Biomet | $103,271 |
| GE HealthCare | $102,133 |
| Biosense Webster, Inc. | $101,200 |
| Trillium Therapeutics USA, LLC | $98,103 |
| Acutus Medical, Inc. | $95,000 |
| Gen-probe, Inc. | $91,933 |
| Angiodynamics, Inc. | $91,000 |
| Acelrx Pharmaceuticals, Inc. | $81,859 |
| Clearpoint Neuro, Inc. | $79,152 |
| Gentuity, LLC | $78,312 |
| Roche Molecular Systems, Inc. | $65,582 |
| Eli Lilly | $63,363 |
| Cvrx, Inc. | $62,698 |
| Hikma Pharmaceuticals USA | $58,571 |